Novateor Research Laboratories sets Sept 29 for 15th AGM

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Novateor Research Laboratories schedules its 15th AGM for September 29, 2026
  • Board reappoints Mehul Raval as Secretarial Auditor for FY27
  • Company considers shifting registered office to Sanand, Ahmedabad
  • Cut-off date for AGM eligibility set as September 25, 2026
powered bylight_fuzz_icon
49996091

*this image is generated using AI for illustrative purposes only.

Novateor Research Laboratories held a board meeting on September 3, 2025, to approve the notice for its 15th Annual General Meeting (AGM) and appoint key auditors for FY27.

The company also considered shifting its registered office from Prahladnagar to Sanand, Ahmedabad, subject to shareholder approval.

Key Board Decisions

The Board of Directors approved several administrative and compliance matters during the meeting held at the company’s registered office.

  • AGM Notice: The contents and resolutions for the 15th AGM were approved. The meeting is scheduled for Tuesday, September 29, 2026, at 3:00 pm.
  • Auditor Appointments: Mr. Mehul Raval was reappointed as Secretarial Auditor for FY27. M/s. N. C. Vasa & Co. was reappointed as Internal Auditor for the same period.
  • Registered Office Shift: The board considered moving the registered office from Dev Atelier, Prahladnagar, to Plot No. PE-11, Sanand-II, GIDC Industrial Estate, Sanand. This requires shareholder approval.
  • Directors’ Report: The draft Directors’ Report for FY26 was approved.

AGM Details

The 15th AGM will be held at the current registered office in Ahmedabad. There are no physical shareholders, so the register of members will not be closed. The cut-off date for eligibility is September 25, 2026.

Historical Stock Returns for Novateor Research Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%+433.33%

What strategic advantages or cost efficiencies does Novateor anticipate from relocating its registered office to the GIDC Industrial Estate in Sanand?

How might the proposed office shift impact the company's operational logistics or local talent acquisition in the Ahmedabad region?

Are there any pending regulatory approvals or municipal clearances required for the new Sanand location that could delay the move?

Novateor Research Laboratories
View Company Insights
View All News
like15
dislike

Novateor Research Laboratories schedules board meeting for Sep 3

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Novateor Research Laboratories schedules board meeting for September 3, 2026
  • Agenda includes approval of matters for the ensuing annual general meeting
  • Disclosure made pursuant to Regulation 29 of SEBI LODR Regulations, 2015
  • Meeting to be held at the registered office in Ahmedabad
powered bylight_fuzz_icon
49739976

*this image is generated using AI for illustrative purposes only.

Novateor Research Laboratories Limited has scheduled a board meeting for September 3, 2026. The session will address the upcoming annual general meeting and other corporate governance matters.

The company issued the intimation on August 31, 2026, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is set to take place at the company's registered office in Ahmedabad.

Agenda Details

The board of directors will consider the following items during the session:

  • Approval of matters related to the ensuing annual meeting of the company
  • Transaction of any other business with the prior approval of the chairman

Navdeep Subhashbha Mehta, Managing Director, digitally signed the disclosure. The company's registered office is located at Dev Atelier in Prahladnagar, Ahmedabad.

Historical Stock Returns for Novateor Research Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%+433.33%

What specific financial results or dividend proposals are expected to be presented at the ensuing annual general meeting?

Are there any anticipated changes to the board composition or executive leadership during this governance review?

How might the outcomes of this meeting influence Novateor's strategic direction in the pharmaceutical research sector for the upcoming fiscal year?

Novateor Research Laboratories
View Company Insights
View All News
like15
dislike

More News on Novateor Research Laboratories

1 Year Returns:0.00%